Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELIEVE: Platelet Rich Plasma for Postpartum Perineal Pain
NCT07727213Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Randomised, triple-blind trial of autologous non-activated platelet-rich plasma in Postpartum pain (PPP) (2 arms). Primary endpoint: Perineal Pain Intensity Assessed by a 100-mm Visual Analogue Scale at 12 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
autologous non-activated platelet-rich plasma
03
Conditions
Postpartum pain (PPP)
Beyond the preview
Go deeper on NCT07727213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07727213.